Argenica Therapeutics Limited (ASX: AGN)
Health Care · Pharmaceuticals · AU
AU$0.13
-13.33% today · -46.9% 1Y
Argenica Therapeutics Limited (ASX: AGN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.65M and employs 7 people.
Over the last twelve months the share price has lost 46.9%, trading between 0.09 and 0.35.
Tweenvest scores Argenica Therapeutics Limited across four factors: quality 41/100, value 50/100. Its strongest factor is value.
AGN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.65M
- Revenue (TTM)
- $3.79M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.08
- 52-week high
- AU$0.35
- 52-week low
- AU$0.09
- Avg volume (3M)
- —
- Shares outstanding
- 128.46M
- Employees
- 7
- Next earnings
- —
About Argenica Therapeutics Limited
Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
- ISIN
- AU0000150328
- Founded
- 2019
- Listed since
- Jun 11, 2021
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ChoA Pharmaceutical Co., LTD.KOSDAQ: A034940 | $11.84M | ₩2,570.00 | -3.20% |
| Daré Bioscience, Inc.NasdaqCM: DARE | $11.82M | $0.75 | -3.01% |
| Hepion Pharmaceuticals, Inc.OTCPK: HEPA | $11.79M | $0.12 | +48.15% |
| AcuCort AB (publ)XSAT: ACUC | $11.70M | Skr0.40 | -19.88% |
| Aspire-Lakewood Holdings, Inc.NasdaqCM: ASBP | $11.64M | $7.85 | -5.48% |
| OncoZenge AB (publ)OM: ONCOZ | $11.54M | Skr3.79 | -9.33% |
| Silva Pharmaceuticals LimitedDSE: SILVAPHL | $11.53M | Tk10.40 | -16.80% |
| IDT Australia LimitedASX: IDT | $11.33M | AU$0.04 | -7.32% |
Figures last refreshed Oct 11, 2026.